| VanEck Australian Subordinated Debt ETF (SUBD) |
Financials |
$3,718 |
Final Dividend/Distribution for period ending 31 Jan 2026
|
30 Jan 2026 9:41AM |
$25.360 |
$25.220 |
fallen by
0.55%
|
|
| VanEck 5-10 Year Australian Government Bond ETF (5GOV) |
Financials |
$94 |
Final Dividend/Distribution for period ending 31 Jan 2026
|
30 Jan 2026 9:41AM |
$51.750 |
$51.620 |
fallen by
0.25%
|
|
| VanEck Australian Corporate Bond Plus ETF (PLUS) |
Financials |
$356 |
Final Dividend/Distribution for period ending 31 Jan 2026
|
30 Jan 2026 9:41AM |
$16.940 |
$16.810 |
fallen by
0.77%
|
|
| Vaneck Australian Fixed Rate Subordinated Debt ETF (FSUB) |
Financials |
$73 |
Final Dividend/Distribution for period ending 31 Jan 2026
|
30 Jan 2026 9:41AM |
$25.310 |
$24.860 |
fallen by
1.78%
|
|
| VanEck Emerging Income Opportunities Active ETF (Managed Fund) (EBND) |
Financials |
$296 |
Final Dividend/Distribution for period ending 31 Jan 2026
|
30 Jan 2026 9:41AM |
$10.940 |
$10.720 |
fallen by
2.01%
|
|
| VanEck 1-5 Year Australian Government Bond ETF (1GOV) |
Financials |
$22 |
Final Dividend/Distribution for period ending 31 Jan 2026
|
30 Jan 2026 9:41AM |
$51.280 |
$51.280 |
fallen by
0%
|
|
| VanEck Global Listed Private Credit (AUD Hedged) ETF (LEND) |
Financials |
$227 |
Final Dividend/Distribution for period ending 31 Jan 2026
|
30 Jan 2026 9:41AM |
$16.730 |
$15.410 |
fallen by
7.89%
|
|
| VanEck Bentham Global Capital Securities Active ETF (Managed Fund) (GCAP) |
Financials |
$50 |
Final Dividend/Distribution for period ending 31 Jan 2026
|
30 Jan 2026 9:41AM |
$8.910 |
$8.900 |
fallen by
0.11%
|
|
| White Energy Company Limited (WEC) ORDINARY FULLY PAID |
Energy |
$93 |
Quarterly Activities Report and Appendix 5B
|
30 Jan 2026 9:41AM |
$0.045 |
$0.210 |
risen by
366.67%
|
|
WEC - Price-sensitive ASX Announcement
Full Release
Key Points
- Entitlement Offer raises $3.2 million (net)
- Exclusive global agency agreement with K.R. Komarek Inc.
- Sale of Mountainside Coal Company Assets
- Core drilling program at Specimen Hill Project, Queensland
- Ionic sampling programs at Tindal project, Northern Territory
- Assistance to joint venture partner Proterra in South Africa
- Significant cash flow activities reported in Appendix 5B
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kingsgate Consolidated Limited (KCN) ORDINARY FULLY PAID |
Materials |
$1,261 |
December 2025 Quarterly Report
|
30 Jan 2026 9:40AM |
$6.700 |
$4.740 |
fallen by
29.25%
|
|
KCN - Price-sensitive ASX Announcement
Full Release
Key Points
- Chatree Gold Mine produced 20,957 ounces of gold and 157,542 ounces of silver.
- Significant cash build with total cash, bullion, and doré increasing to A$179 million.
- All-in Sustaining Cost (AISC) of US$2,296 per ounce, with a record AISC margin of US$1,871 per ounce.
- FY26 production guidance remains on track.
- Kingsgate was the second-best performing stock in the ASX All Ordinaries for 2025.
- Thailand-Australia Free Trade Agreement arbitration proceedings terminated.
- Operational improvements at Chatree, including enhanced mining rates with new equipment.
- Community initiatives like the Village Development Fund and recognition for workplace safety and health.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Black Rock Mining Limited (BKT) ORDINARY FULLY PAID |
Materials |
$26 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 9:40AM |
$0.019 |
$0.012 |
fallen by
36.84%
|
|
BKT - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of the resettlement action plan for the Mahenge Graphite Project.
- Start of the 220kV transmission line construction.
- Successful A$4 million share purchase plan oversubscription.
- A$9.6 million in cash reserves at the end of December 2025.
- Ongoing financing discussions for project completion.
- No substantive exploration or mining activities reported for the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Papyrus Australia Limited (PPY) ORDINARY FULLY PAID |
Materials |
$5 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 9:40AM |
$0.010 |
$0.008 |
fallen by
20%
|
|
PPY - Price-sensitive ASX Announcement
Full Release
Key Points
- Contract execution with TBS Mining Solutions Pty Ltd for biodegradable Collar Keeper® products.
- Installation and commissioning of the Rapid Prototyping and R&D Facility.
- Discontinuation of legal proceedings by Perfection Australia Group Pty Ltd and Union Pacific Equities Pty Ltd.
- Receipt of $80,000 from the exercise of options, $350,000 in loans, and a $510k tax refund under the FY25 R&D Tax Incentive Program.
- Net cash at the end of the quarter was $471k.
- Development of the Adelaide Rapid Prototyping and R&D Facility nearing completion.
- Papyrus is the exclusive global producer of the biodegradable Collar Keeper® product.
- Operational activities focus on transitioning from technology development to commercial production.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arcadia Minerals Limited (AM7) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$6 |
Suspension from Quotation
|
30 Jan 2026 9:40AM |
$0.036 |
$0.042 |
risen by
16.67%
|
|
AM7 - Price-sensitive ASX Announcement
Full Release
Key Points
- Arcadia Minerals Limited requests suspension from quotation under ASX listing rule 17.2.
- The suspension is pending announcements related to capital raising and the Swanson Tantalum mine.
- The suspension follows a trading halt initiated on 28 January 2026.
- Suspension will last until 2 February 2026 or upon earlier announcement release.
- Arcadia states no additional disclosures are necessary.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Artrya Limited (AYA) ORDINARY FULLY PAID |
Health Care |
$782 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 9:39AM |
$3.740 |
$4.800 |
risen by
28.34%
|
|
AYA - Price-sensitive ASX Announcement
Full Release
Key Points
- Artrya Limited released its Quarterly Activities/Appendix 4C Cash Flow Report for the quarter ended 31 December 2025.
- The company commercialized its Salix® AI-powered platform for coronary artery disease management.
- Artrya signed contracts with Cone Health and Northeast Georgia Health System, achieving its first fee-per-scan revenues.
- The SAPPHIRE Study was launched with major U.S. hospitals participating.
- Artrya advanced its Salix® Coronary Flow module aiming for FDA clearance by mid-2026.
- The company's cash position at the end of the quarter was $76.5 million, with an additional $5.6 million R&D tax rebate expected.
- A $30 million term deposit was made, affecting cash flow classification.
- Artrya was included in the S&P/ASX All Technology Index.
- The company completed an $80 million capital raising to support U.S. commercial activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Infinity Metals Limited (INF) ORDINARY FULLY PAID |
Materials |
$5 |
Quarterly Activities Report
|
30 Jan 2026 9:39AM |
$0.015 |
$0.008 |
fallen by
46.67%
|
|
INF - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling completed at Cobungra EL7073 in Australia with low-moderate grade mineralisation results.
- Awaiting feedback on San José Mining Licence Application in Spain.
- Exploration licence granted in New South Wales for tin-lithium prospect.
- Cash balance of A$2.25 million as of 31 December 2025.
- Continued assessment of opportunities for gold, copper, and silver assets in Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Conneqt Health Limited (CQT) ORDINARY FULLY PAID |
Health Care |
$18 |
December Quarterly Activities Report
|
30 Jan 2026 9:39AM |
$0.045 |
$0.019 |
fallen by
57.78%
|
|
CQT - Price-sensitive ASX Announcement
Full Release
Key Points
- CONNEQT Health's Pulse sales grew over 200% quarter-on-quarter.
- The company transitioned to a higher steady-state device price and subscription model.
- Enterprise strategy shifted to recurring, usage-based contracts from pilot projects.
- Completed a A$3.1 million institutional placement to enhance the balance sheet.
- Cash receipts from operations increased by 96% compared to the prior quarter.
- Centralized R&D and engineering activities led to a 30% reduction in costs.
- Customer engagement increased significantly, with automated support handling first-line inquiries.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Infinity Metals Limited (INF) ORDINARY FULLY PAID |
Materials |
$5 |
Quarterly Cashflow Report
|
30 Jan 2026 9:38AM |
$0.015 |
$0.008 |
fallen by
46.67%
|
|
INF - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash outflow from operating activities was $333,000 for the quarter.
- Year-to-date operating cash outflow totaled $884,000.
- Exploration and evaluation expenses were $45,000 for the quarter.
- Investing activities resulted in a cash outflow of $89,000 for the quarter.
- No cash inflows from financing activities.
- Cash reserves at the end of the quarter were $2,247,000.
- Estimated cash reserves sufficient for 5.3 quarters of operation.
- Report prepared in line with ASX listing rules and Australian accounting standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Conneqt Health Limited (CQT) ORDINARY FULLY PAID |
Health Care |
$18 |
December Quarterly Appendix 4C
|
30 Jan 2026 9:38AM |
$0.045 |
$0.019 |
fallen by
57.78%
|
|
CQT - Price-sensitive ASX Announcement
Full Release
Key Points
- CONNEQT Health Limited reported a net cash usage of $1.894 million from operating activities for the current quarter.
- Cash and cash equivalents at the end of the quarter amounted to $2.430 million.
- An Institutional Placement raised $3.1 million, including $1.2 million from C2V.
- The company received a 2025 R&D Tax Incentive Refund of $1.63 million, partially used to repay the R&D loan facility.
- There is an ongoing effort to reduce operational costs, notably by centralizing operations in Sydney.
- Estimated quarters of funding available is 1.28, highlighting the need for future capital raises.
- The company is exploring further R&D and inventory financing facilities between $1.5-2.5 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Adheris Health Limited (AHE) ORDINARY FULLY PAID |
Health Care |
$11 |
2Q FY26 Quarterly Activity Report and Appendix 4C
|
30 Jan 2026 9:38AM |
$0.022 |
$0.017 |
fallen by
22.73%
|
|
AHE - Price-sensitive ASX Announcement
Full Release
Key Points
- John Ciccio was appointed as the CEO and Managing Director, succeeding Rick Ratliff.
- The company's focus shifted to stabilizing the business, reducing operating costs, and capturing pipeline opportunities.
- Q2 FY26 operating revenue was $13.7 million, a decrease of 45.8% from the previous corresponding period.
- A new technology platform was launched to enhance omnichannel delivery and support growth.
- The report highlights a significant decrease in gross profit and margin, reflecting lower revenue and cost allocations.
- The company received a holdback payment of $6.1 million from the sale of its ANZ business.
- Net cash at the end of the period was $8.1 million, with a pro-forma cash position of $14.2 million post-receipt of the holdback payment.
- Adheris Health aims to accelerate product innovation, improve execution, and use AI for personalization.
- The company plans to expand its pharmacy network and enhance its digital engagement suite.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kairos Minerals Limited (KAI) ORDINARY FULLY PAID |
Materials |
- |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 9:37AM |
$0.036 |
$0.710 |
risen by
1,872.22%
|
|
KAI - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of 128 drill holes at Mt York Gold Project.
- High-grade drilling results at Main Hill and Breccia Hill.
- Landmark mining agreement with Nyamal Aboriginal Corporation.
- Raised approximately A$27 million through placements.
- Cash balance of $25.0 million with an additional $10 million expected.
- Plans for further exploration and resource estimation updates.
- Preparation for a prefeasibility study at Mt York.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Superior Resources Limited (SPQ) ORDINARY FULLY PAID |
Materials |
$11 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 9:37AM |
$0.007 |
$0.004 |
fallen by
42.86%
|
|
SPQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Superior Resources Limited reported its quarterly activities ending 31 December 2025.
- Focus was on advancing the Greenvale Project, particularly the Steam Engine Gold Project.
- Net cash inflow from financing activities was primarily from equity securities issuance.
- Significant drilling programs are planned for Q1 2026.
- Exploration efforts aim to increase gold resources and feasibility of standalone processing.
- Strong cash position at the end of the quarter ensures funding for future operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Medallion Metals Limited (MM8) ORDINARY FULLY PAID |
Materials |
$414 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jan 2026 9:36AM |
$0.495 |
$0.515 |
risen by
4.04%
|
|
MM8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Progress on Ravensthorpe Gold Project and Forrestania Nickel Operation acquisition.
- Planning and commencement of drilling at Kundip Mining Centre.
- Capital raising of $55 million for development activities.
- Cash and cash equivalents at $68.1 million at quarter-end.
- Net cash outflows from operating activities of $2.6 million.
- Net cash inflows from financing activities of $47.6 million.
- No new farm-in or farm-out agreements during the quarter.
- Updates on tenement interests for Parker Dome and Ravensthorpe projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Peninsula Energy Limited (PEN) ORDINARY FULLY PAID |
Energy |
$183 |
Quarterly Activities Report
|
30 Jan 2026 9:36AM |
$0.955 |
$0.320 |
fallen by
66.49%
|
|
PEN - Price-sensitive ASX Announcement
Full Release
Key Points
- Commissioning of key systems within the Lance Central Processing Plant continued.
- Permanent piping replacement in Phase 1 of the CPP was completed.
- MU-4 expected to offset lower flow rates from Mine Unit 3.
- Peninsula is on track to meet uranium production guidance for CY2026.
- Review of existing drill data at Dagger Exploration Project continues.
- Funding package for Horizon 21 growth completed with A$69.9 million raise.
- Davidson Kempner debt facility fully drawn, US$3 million converted to equity.
- Annual General Meeting of Shareholders held with all resolutions carried.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AdNeo Limited (AD1) ORDINARY FULLY PAID |
Communication Services |
$11 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jan 2026 9:35AM |
$0.033 |
$0.030 |
fallen by
9.09%
|
|
AD1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Receipts from customers increased by 89% to $2.69 million.
- Net cash outflow from operations was $14k.
- Operating expenses included $500k of non-recurring costs.
- Identified $1.5 million in additional cost savings.
- Reduced balance sheet liabilities by $1.35 million.
- Strong sales pipeline with new contract wins.
- Focus on reaching cash flow positivity in FY26.
- First full quarter after acquiring Learnt Group and Aspire Learning.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Impact Minerals Limited (IPT) ORDINARY FULLY PAID |
Materials |
$21 |
Quarterly Activities Report
|
30 Jan 2026 9:35AM |
$0.068 |
$0.041 |
fallen by
39.71%
|
|
IPT - Price-sensitive ASX Announcement
Full Release
Key Points
- Continuation of research and test work on High Purity Alumina (HPA) Project.
- Technology Collaboration Agreement with C4V for HPA Commercialisation.
- Kuniko secures right to earn up to 70% of Commonwealth Project.
- Resumed exploration at Broken Hill due to increased metal prices.
- Completion of a diamond drill hole with significant metal intercepts.
- Identification of proprietary multi-metal ratio for real-time exploration.
- Cash at the end of December 2025 was $3.37 million.
- No new material information affecting previous mineral resource estimates.
- Exploration and corporate expenses detailed in the quarterly report.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
